SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Marizyme Inc. – ‘10-K’ for 12/31/20 – ‘EX-101.SCH’

On:  Thursday, 4/15/21, at 5:16pm ET   ·   For:  12/31/20   ·   Accession #:  1493152-21-8936   ·   File #:  0-53223

Previous ‘10-K’:  ‘10-K’ on 4/15/20 for 12/31/19   ·   Next:  ‘10-K’ on 3/31/22 for 12/31/21   ·   Latest:  ‘10-K’ on 3/24/23 for 12/31/22   ·   21 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/21  Marizyme Inc.                     10-K       12/31/20   74:5.4M                                   M2 Compliance LLC/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    836K 
 8: EX-10.10    Material Contract                                   HTML     22K 
 9: EX-10.11    Material Contract                                   HTML     22K 
10: EX-10.12    Material Contract                                   HTML     52K 
 2: EX-10.4     Material Contract                                   HTML     55K 
 3: EX-10.5     Material Contract                                   HTML     55K 
 4: EX-10.6     Material Contract                                   HTML     56K 
 5: EX-10.7     Material Contract                                   HTML    113K 
 6: EX-10.8     Material Contract                                   HTML     63K 
 7: EX-10.9     Material Contract                                   HTML     21K 
11: EX-21       Subsidiaries List                                   HTML     19K 
12: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
13: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
14: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
15: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
22: R1          Document and Entity Information                     HTML     59K 
23: R2          Consolidated Balance Sheets                         HTML     97K 
24: R3          Consolidated Balance Sheets (Parenthetical)         HTML     37K 
25: R4          Consolidated Statements of Operations               HTML     64K 
26: R5          Consolidated Statements of Changes in               HTML     69K 
                Stockholders' Equity                                             
27: R6          Consolidated Statements of Cash Flows               HTML     95K 
28: R7          Organization and Description of Business            HTML     32K 
29: R8          Going Concern                                       HTML     24K 
30: R9          Summary of Significant Accounting Policies          HTML     54K 
31: R10         Lease                                               HTML     31K 
32: R11         Acquisitions                                        HTML     33K 
33: R12         Commitments and Contingencies                       HTML     31K 
34: R13         Fixed Assets                                        HTML     27K 
35: R14         Intangible Assets                                   HTML     36K 
36: R15         Related Party Transactions                          HTML     23K 
37: R16         Stockholders' Equity                                HTML     57K 
38: R17         Income Taxes                                        HTML     41K 
39: R18         Subsequent Events                                   HTML     28K 
40: R19         Summary of Significant Accounting Policies          HTML    110K 
                (Policies)                                                       
41: R20         Summary of Significant Accounting Policies          HTML     29K 
                (Tables)                                                         
42: R21         Lease (Tables)                                      HTML     31K 
43: R22         Acquisitions (Tables)                               HTML     26K 
44: R23         Fixed Assets (Tables)                               HTML     27K 
45: R24         Intangible Assets (Tables)                          HTML     36K 
46: R25         Stockholders' Equity (Tables)                       HTML     42K 
47: R26         Income Taxes (Tables)                               HTML     40K 
48: R27         Organization and Description of Business (Details   HTML     28K 
                Narrative)                                                       
49: R28         Going Concern (Details Narrative)                   HTML     36K 
50: R29         Summary of Significant Accounting Policies          HTML     57K 
                (Details Narrative)                                              
51: R30         Summary of Significant Accounting Policies -        HTML     27K 
                Schedule of Useful Life of Fixed Assets (Details)                
52: R31         Summary of Significant Accounting Policies -        HTML     33K 
                Schedule of Reconciliation of Basic and Diluted                  
                Earnings (Loss) (Details)                                        
53: R32         Lease (Details Narrative)                           HTML     35K 
54: R33         Lease - Schedule of Right-of-use Asset and Related  HTML     28K 
                Lease Liability (Details)                                        
55: R34         Lease - Schedule of Maturities of the Lease         HTML     40K 
                Liabilities (Details)                                            
56: R35         Acquisitions (Details Narrative)                    HTML     82K 
57: R36         Acquisitions - Schedule of Preliminary Allocation   HTML     39K 
                of Consideration (Details)                                       
58: R37         Commitments And Contingencies (Details Narrative)   HTML     60K 
59: R38         Fixed Assets (Details Narrative)                    HTML     22K 
60: R39         Fixed Assets - Schedule of Property, Plant, and     HTML     32K 
                Equipment (Details)                                              
61: R40         Intangible Assets (Details Narrative)               HTML     39K 
62: R41         Intangible Assets - Summary of Intangible Assets    HTML     33K 
                Amortization Expense (Details)                                   
63: R42         Intangible Assets - Schedule of Intangible Assets   HTML     28K 
                (Details)                                                        
64: R43         Stockholders' Equity (Details Narrative)            HTML    331K 
65: R44         Stockholders' Equity - Schedule of Stock Option     HTML     49K 
                Activity (Details)                                               
66: R45         Stockholders' Equity - Schedule of Options          HTML     54K 
                Outstanding and Exercisable (Details)                            
67: R46         Income Taxes (Details Narrative)                    HTML     26K 
68: R47         Income Taxes - Schedule of Income Tax Expense       HTML     33K 
                (Details)                                                        
69: R48         Income Taxes - Schedule of Effective Income Tax     HTML     33K 
                Rates (Details)                                                  
70: R49         Income Taxes - Schedule of Deferred Tax Assets and  HTML     34K 
                Liabilities (Details)                                            
71: R50         Subsequent Events (Details Narrative)               HTML     79K 
73: XML         IDEA XML File -- Filing Summary                      XML    113K 
72: EXCEL       IDEA Workbook of Financial Reports                  XLSX     83K 
16: EX-101.INS  XBRL Instance -- mrzm-20201231                       XML   1.02M 
18: EX-101.CAL  XBRL Calculations -- mrzm-20201231_cal               XML    144K 
19: EX-101.DEF  XBRL Definitions -- mrzm-20201231_def                XML    439K 
20: EX-101.LAB  XBRL Labels -- mrzm-20201231_lab                     XML    862K 
21: EX-101.PRE  XBRL Presentations -- mrzm-20201231_pre              XML    677K 
17: EX-101.SCH  XBRL Schema -- mrzm-20201231                         XSD    127K 
74: ZIP         XBRL Zipped Folder -- 0001493152-21-008936-xbrl      Zip    111K

‘EX-101.SCH’   —   XBRL Schema — mrzm-20201231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Source; Value: MRZM 20201231 10K FY DFN.xfr; Date: 2021%2D04%2D15T20:34:37Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaOMmbP9z5Z8KekhvWB9bYmK3yAp4xo1aivkJxwGYYEN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:mrzm="http://marizyme.com/20201231" elementFormDefault="qualified" targetNamespace="http://marizyme.com/20201231">
<annotation>
<appinfo>
<link:roleType roleURI="http://marizyme.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition> 00000001 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/BalanceSheets" id="BalanceSheets">
<link:definition> 00000002 - Statement - Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
<link:definition> 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StatementsOfOperations" id="StatementsOfOperations">
<link:definition> 00000004 - Statement - Consolidated Statements of Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StatementsOfChangesInStockholdersEquity" id="StatementsOfChangesInStockholdersEquity">
<link:definition> 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
<link:definition> 00000006 - Statement - Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/OrganizationAndDescriptionOfBusiness" id="OrganizationAndDescriptionOfBusiness">
<link:definition> 00000007 - Disclosure - Organization and Description of Business </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/GoingConcern" id="GoingConcern">
<link:definition> 00000008 - Disclosure - Going Concern </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 00000009 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/Lease" id="Lease">
<link:definition> 00000010 - Disclosure - Lease </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/Acquisitions" id="Acquisitions">
<link:definition> 00000011 - Disclosure - Acquisitions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 00000012 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/FixedAssets" id="FixedAssets">
<link:definition> 00000013 - Disclosure - Fixed Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IntangibleAssets" id="IntangibleAssets">
<link:definition> 00000014 - Disclosure - Intangible Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition> 00000015 - Disclosure - Related Party Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StockholdersEquity" id="StockholdersEquity">
<link:definition> 00000016 - Disclosure - Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition> 00000017 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 00000018 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition> 00000020 - Disclosure - Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/LeaseTables" id="LeaseTables">
<link:definition> 00000021 - Disclosure - Lease (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/AcquisitionsTables" id="AcquisitionsTables">
<link:definition> 00000022 - Disclosure - Acquisitions (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/FixedAssetsTables" id="FixedAssetsTables">
<link:definition> 00000023 - Disclosure - Fixed Assets (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
<link:definition> 00000024 - Disclosure - Intangible Assets (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
<link:definition> 00000025 - Disclosure - Stockholders' Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition> 00000026 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" id="OrganizationAndDescriptionOfBusinessDetailsNarrative">
<link:definition> 00000027 - Disclosure - Organization and Description of Business (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
<link:definition> 00000028 - Disclosure - Going Concern (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
<link:definition> 00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfUsefulLifeOfFixedAssetsDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfUsefulLifeOfFixedAssetsDetails">
<link:definition> 00000030 - Disclosure - Summary of Significant Accounting Policies - Schedule of Useful Life of Fixed Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfBasicAndDilutedEarningsLossDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfReconciliationOfBasicAndDilutedEarningsLossDetails">
<link:definition> 00000031 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of Basic and Diluted Earnings (Loss) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/LeaseDetailsNarrative" id="LeaseDetailsNarrative">
<link:definition> 00000032 - Disclosure - Lease (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/Lease-ScheduleOfRight-of-useAssetAndRelatedLeaseLiabilityDetails" id="Lease-ScheduleOfRight-of-useAssetAndRelatedLeaseLiabilityDetails">
<link:definition> 00000033 - Disclosure - Lease - Schedule of Right-of-use Asset and Related Lease Liability (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/Lease-ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" id="Lease-ScheduleOfMaturitiesOfLeaseLiabilitiesDetails">
<link:definition> 00000034 - Disclosure - Lease - Schedule of Maturities of the Lease Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/AcquisitionsDetailsNarrative" id="AcquisitionsDetailsNarrative">
<link:definition> 00000035 - Disclosure - Acquisitions (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/Acquisitions-ScheduleOfPreliminaryAllocationOfConsiderationDetails" id="Acquisitions-ScheduleOfPreliminaryAllocationOfConsiderationDetails">
<link:definition> 00000036 - Disclosure - Acquisitions - Schedule of Preliminary Allocation of Consideration (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
<link:definition> 00000037 - Disclosure - Commitments And Contingencies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/FixedAssetsDetailsNarrative" id="FixedAssetsDetailsNarrative">
<link:definition> 00000038 - Disclosure - Fixed Assets (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/FixedAssets-ScheduleOfPropertyPlantAndEquipmentDetails" id="FixedAssets-ScheduleOfPropertyPlantAndEquipmentDetails">
<link:definition> 00000039 - Disclosure - Fixed Assets - Schedule of Property, Plant, and Equipment (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
<link:definition> 00000040 - Disclosure - Intangible Assets (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IntangibleAssets-SummaryOfIntangibleAssetsAmortizationExpenseDetails" id="IntangibleAssets-SummaryOfIntangibleAssetsAmortizationExpenseDetails">
<link:definition> 00000041 - Disclosure - Intangible Assets - Summary of Intangible Assets Amortization Expense (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" id="IntangibleAssets-ScheduleOfIntangibleAssetsDetails">
<link:definition> 00000042 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
<link:definition> 00000043 - Disclosure - Stockholders' Equity (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StockholdersEquity-ScheduleOfStockOptionActivityDetails" id="StockholdersEquity-ScheduleOfStockOptionActivityDetails">
<link:definition> 00000044 - Disclosure - Stockholders' Equity - Schedule of Stock Option Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/StockholdersEquity-ScheduleOfOptionsOutstandingAndExercisableDetails" id="StockholdersEquity-ScheduleOfOptionsOutstandingAndExercisableDetails">
<link:definition> 00000045 - Disclosure - Stockholders' Equity - Schedule of Options Outstanding and Exercisable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
<link:definition> 00000046 - Disclosure - Income Taxes (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IncomeTaxes-ScheduleOfIncomeTaxExpenseDetails" id="IncomeTaxes-ScheduleOfIncomeTaxExpenseDetails">
<link:definition> 00000047 - Disclosure - Income Taxes - Schedule of Income Tax Expense (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRatesDetails" id="IncomeTaxes-ScheduleOfEffectiveIncomeTaxRatesDetails">
<link:definition> 00000048 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rates (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
<link:definition> 00000049 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://marizyme.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
<link:definition> 00000050 - Disclosure - Subsequent Events (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="mrzm-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mrzm-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mrzm-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mrzm-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
<import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
<import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
<import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
<import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd"/>
<element id="mrzm_DepositsNoncurrent" name="DepositsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_DirectCostsOfRevenue" name="DirectCostsOfRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ForgivenessOfDebtForServices" name="ForgivenessOfDebtForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_IssuanceOfCommonStockInLieuOfAccountsPayable" name="IssuanceOfCommonStockInLieuOfAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_IssuanceOfWarrantsForServices" name="IssuanceOfWarrantsForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ScheduleOfUsefulLifeOfFixedAssets" name="ScheduleOfUsefulLifeOfFixedAssets" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantsGiven" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantsGiven" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_WorkingCapitalSurplus" name="WorkingCapitalSurplus" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_BadDebtExpense" name="BadDebtExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_RoyaltiesPercentage" name="RoyaltiesPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_PercentageOfAllocationToIntangibleAssets" name="PercentageOfAllocationToIntangibleAssets" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_CommissionsPaidForServicesRendered" name="CommissionsPaidForServicesRendered" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_NonaccountableExpensesAllowancePaid" name="NonaccountableExpensesAllowancePaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsRemainingStockOptionVestPerMonthAtGrant" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsRemainingStockOptionVestPerMonthAtGrant" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_FairMarketValueOfWarrant" name="FairMarketValueOfWarrant" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_FairMarketValueOfWarrantPerShare" name="FairMarketValueOfWarrantPerShare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_AccumulatedAmortizationOfIntangibleAssets" name="AccumulatedAmortizationOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_PrepaidRoyaltiesOthers" name="PrepaidRoyaltiesOthers" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_IncreaseDecreaseInDepositsAssets" name="IncreaseDecreaseInDepositsAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForService" name="AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForService" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_BaseRentPercentage" name="BaseRentPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_DeferredTaxAssetsLeaseLiability" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ScheduleOfRightofuseAssetAndRelatedLeaseLiabilityTableTextBlock" name="ScheduleOfRightofuseAssetAndRelatedLeaseLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_IssuanceOfCommonStockForServices" name="IssuanceOfCommonStockForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_FairValueOfCommonStockAndWarrants" name="FairValueOfCommonStockAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_StockbasedCompensationAndStockIssuedForServices" name="StockbasedCompensationAndStockIssuedForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_InitialAdoptionOfRouAssetAndLeaseLiability" name="InitialAdoptionOfRouAssetAndLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_CustomerConcentrationsPolicyTextBlock" name="CustomerConcentrationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_FurnitureandEquipmentMember" name="FurnitureandEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ComputerRelatedMember" name="ComputerRelatedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_KrillaseTechnologyMember" name="KrillaseTechnologyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_SomahMember" name="SomahMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_SomahlutionIncMember" name="SomahlutionIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_OneSalesMember" name="OneSalesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_TwoSalesMember" name="TwoSalesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_MukeshkkumarBPatelMember" name="MukeshkkumarBPatelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_FirstFiftyMillionMember" name="FirstFiftyMillionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_FiftyMillionUpToTwoHundredMillionMember" name="FiftyMillionUpToTwoHundredMillionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_OverTwoHundredMillionMember" name="OverTwoHundredMillionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_EmploymentAndConsultingAgreementsMember" name="EmploymentAndConsultingAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_JulyThirteenTwoThousandandTwentyTwoMember" name="JulyThirteenTwoThousandandTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_JulyThirteenTwoThousandandTwentyOneMember" name="JulyThirteenTwoThousandandTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ConsultantMember" name="ConsultantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_TwoConsultantMember" name="TwoConsultantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_AccreditedInvestorsMember" name="AccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_PlacementAgentMember" name="PlacementAgentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_OfficerDirectorAndConsultantMember" name="OfficerDirectorAndConsultantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ConsultantOneMember" name="ConsultantOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_EmployeeMember" name="EmployeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ConsultantTwoMember" name="ConsultantTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ChiefExecutiveOfficerPresidentAndDirectorMember" name="ChiefExecutiveOfficerPresidentAndDirectorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_EmployeeOneMember" name="EmployeeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ChiefMedicalOfficerMember" name="ChiefMedicalOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_WarrantOneMember" name="WarrantOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_WarrantTwoMember" name="WarrantTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_WarrantOneAndTwoMember" name="WarrantOneAndTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ExercisePriceRangeAtOnePointZeroOneMember" name="ExercisePriceRangeAtOnePointZeroOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ExercisePriceRangeAtOnePointTwoFiveMember" name="ExercisePriceRangeAtOnePointTwoFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ExercisePriceRangeAtOnePointThreeSevenMember" name="ExercisePriceRangeAtOnePointThreeSevenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ExercisePriceRangeAtOnePointFiveZeroMember" name="ExercisePriceRangeAtOnePointFiveZeroMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ExecutiveVicePresidentOneMember" name="ExecutiveVicePresidentOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_DirectorOneMember" name="DirectorOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_DirectorTwoMember" name="DirectorTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_DirectorThreeMember" name="DirectorThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_XAssetsEnterprisesIncMember" name="XAssetsEnterprisesIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_ACBHoldingABMember" name="ACBHoldingABMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_KrillasePatentsPatentApplicationsResearchAndDevelopmentClinicalTrialsDevelopedTechnologyMember" name="KrillasePatentsPatentApplicationsResearchAndDevelopmentClinicalTrialsDevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_DuraGraftPatentsPatentApplicationsResearchAndDevelopmentClinicalTrialsDevelopedTechnologyMember" name="DuraGraftPatentsPatentApplicationsResearchAndDevelopmentClinicalTrialsDevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_FourCustomerMember" name="FourCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_NoCustomerMember" name="NoCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_OperatingLeaseAgreementMember" name="OperatingLeaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_CommonStockOneMember" name="CommonStockOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_CommonStockTwoMember" name="CommonStockTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_GoingConcernDetailsNarrativeAbstract" name="GoingConcernDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="mrzm_CommitmentsAndContingenciesDetailsNarrativeAbstract" name="CommitmentsAndContingenciesDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
</schema>

14 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/24/23  Marizyme, Inc.                    424B3                  1:70K                                    M2 Compliance LLC/FA
10/24/23  Marizyme, Inc.                    8-K:5,9    10/18/23   11:4.4M                                   M2 Compliance LLC/FA
 3/24/23  Marizyme, Inc.                    10-K       12/31/22   75:8.5M                                   M2 Compliance LLC/FA
 2/13/23  Marizyme, Inc.                    S-1/A                 76:13M                                    M2 Compliance LLC/FA
 2/09/23  Marizyme, Inc.                    S-1/A                 80:13M                                    M2 Compliance LLC/FA
 2/01/23  Marizyme, Inc.                    S-1/A                 80:16M                                    M2 Compliance LLC/FA
11/16/22  Marizyme, Inc.                    S-1/A                 85:10M                                    EdgarAgents LLC/FA
11/02/22  Marizyme, Inc.                    S-1/A                103:12M                                    EdgarAgents LLC/FA
 3/31/22  Marizyme, Inc.                    10-K       12/31/21   84:72M                                    M2 Compliance LLC/FA
 2/14/22  Marizyme, Inc.                    S-1                  112:92M                                    M2 Compliance LLC/FA
11/22/21  Marizyme, Inc.                    10-Q        9/30/21   70:4.7M                                   M2 Compliance LLC/FA
11/22/21  Marizyme, Inc.                    10-Q/A      6/30/21   72:7.3M                                   M2 Compliance LLC/FA
 8/23/21  Marizyme, Inc.                    10-Q        6/30/21   67:6.2M                                   M2 Compliance LLC/FA
 5/06/21  Marizyme, Inc.                    10-Q        3/31/21   58:2.9M                                   M2 Compliance LLC/FA

7 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/06/20  Marizyme, Inc.                    8-K:1,9    11/01/20    3:235K                                   Action Edgar Fil… Svc/FA
 8/14/20  Marizyme, Inc.                    10-Q        6/30/20   34:1.4M                                   Action Edgar Fil… Svc/FA
11/13/19  Marizyme, Inc.                    10-Q        9/30/19   35:1.2M                                   Action Edgar Fil… Svc/FA
 9/12/18  Marizyme, Inc.                    10-12G      9/13/18   11:5.2M                                   Action Edgar Fil… Svc/FA
 7/16/12  Marizyme Inc.                     10-K        3/31/12   53:4.5M                                   Toppan Merrill/FA
 7/15/11  Marizyme Inc.                     10-K/A      3/31/11    7:723K                                   Toppan Merrill/FA
10/16/07  Marizyme Inc.                     SB-2                   8:922K                                   Newsfile Corp./FA
↑Top
Filing Submission 0001493152-21-008936   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 1, 9:38:50.3pm ET